McKesson, drug distributors face $95 billion opioid trial in Washington state_老虎社区_美港股上老虎

McKesson, drug distributors face $95 billion opioid trial in Washington state

Reuters2021-11-15

A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused of fueling the U.S. opioid epidemic is slated to kick off on Monday, after the state's attorney ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

ShenGY
·2021-11-15
👍
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1189924614?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-15 19:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189924614","market":"us","top_or_hot":-1,"title":"McKesson, drug distributors face $95 billion opioid trial in Washington state","media":"Reuters","content":"<div>\n<p>A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused of fueling the U.S. opioid epidemic is slated to kick off on Monday, after the state's attorney ...</p>\n\n<a href=\"https://www.reuters.com/world/us/mckesson-drug-distributors-face-95-billion-opioid-trial-washington-state-2021-11-15/\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>McKesson, drug distributors face $95 billion opioid trial in Washington state</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMcKesson, drug distributors face $95 billion opioid trial in Washington state\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-15 19:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/world/us/mckesson-drug-distributors-face-95-billion-opioid-trial-washington-state-2021-11-15/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused of fueling the U.S. opioid epidemic is slated to kick off on Monday, after the state's attorney ...</p>\n\n<a href=\"https://www.reuters.com/world/us/mckesson-drug-distributors-face-95-billion-opioid-trial-washington-state-2021-11-15/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"JNJ","symbol_name":"强生","start_time":0,"source_url":"https://www.reuters.com/world/us/mckesson-drug-distributors-face-95-billion-opioid-trial-washington-state-2021-11-15/","article_id":"1189924614","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189924614","pubTimestamp":1636976498,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused","collect":0,"end_time":0,"defaultTopTitle":"reuters.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"JNJ":"强生","MCK":"麦克森药物批发"},"translate_title":"麦克森，药物经销商在华盛顿州面临950亿美元的阿片类药物审判","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":0.9,"MCK":0.9},"content_text":"A trial pitting Washington state against McKesson Corp(MCK.N)and two other drug distributors accused of fueling the U.S. opioid epidemic is slated to kick off on Monday, after the state's attorney general declined to join a $26 billion nationwide settlement.\nWashington Attorney General Bob Ferguson has accused McKesson, Cardinal Health Inc(CAH.N)and AmerisourceBergen Corp(ABC.N)of creating a public nuisance by failing to prevent the diversion of prescription pills into illegal channels.\nWashington is seeking $38.2 billion to fund treatment and other programs and billions more in penalties and forfeited profits. The distributors, who deny wrongdoing, say the state wants a \"wildly inflated recovery\" of more than $95 billion.\nMore than 3,300 lawsuits by largely state and local governments have been filed seeking to hold those and other companies responsible for a drug abuse crisis the U.S. government says led to nearly 500,000 opioid overdose deaths over two decades.\nWashington state would have been eligible for $527.5 million if it had joined a proposed global deal, under which the distributors would pay up to$21 billionand drugmaker Johnson & Johnson(JNJ.N)would pay $5 billion to resolve the cases.\nFerguson, a Democrat, has criticized the settlement as \"not nearly good enough,\" saying the nearly $30 million on average the state and its communities would receive annually was insufficient to address the devastation caused by the epidemic.\nThe state became one of eight to not participate in the distributors' nationwide accord and opted to proceed to trial.\n\"Washington families devastated by the opioid epidemic deserve their day in court,\" Ferguson said in a statement.\nThe companies deny wrongdoing, arguing that the increase in pills was due to rising prescriptions and other factors and that they had systems in place to prevent drug diversion. They argue that distributing regulated drugs cannot support a public nuisance claim.\nPlaintiffs in some of the other opioid cases have recently faced setbacks pursuing nuisance claims.\nOklahoma's top court on Tuesday overturned a $465 million judgment against J&J, and a California judge this month ruled in favor of four drugmakers in a case brought by several large counties.\nThe distributors are awaiting a decision in a similar case in West Virginia following a trial. Closing arguments are expected Monday in Ohio in the first trial pharmacies have faced over the epidemic.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":873470772,"gmtCreate":1636982241351,"gmtModify":1636982783346,"author":{"id":"4099261143755430","authorId":"4099261143755430","name":"ShenGY","avatar":"https://static.tigerbbs.com/e3a5b601d7373e94cf8257ec4aec4f52","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4099261143755430","authorIdStr":"4099261143755430"},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873470772","repostId":1189924614,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":17,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}